# ClinicalTrials.gov record history: NCT05530577

- Peptide profile: [semaglutide](https://peptidescanner.com/peptides/semaglutide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct05530577-semaglutide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct05530577.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `8e0ec51d3deb0bff82dfac6c2dc7b2561296918fdee5a89b237170a815c1af78`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2022-09-01 | 2022-09-01 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=1&tab=history) | `3e7df4bf72a157c154376768590783d11d7b27adb59e13744037ba12d89fa9e2` |
| 2 | 2022-10-21 | 2022-10-21 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=2&tab=history) | `3a754058b37fe93a5be5d0e22f6f777ff7a843f6dc012aed7dffe96bed1e6274` |
| 3 | 2023-11-14 | 2023-11-14 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=3&tab=history) | `e5cd684a772c24446d3c6b082b7c72fbb579947734f4ab265b385eea925fd978` |
| 4 | 2024-08-12 | 2024-08-12 | COMPLETED | INTERVENTIONAL | Contacts/Locations, Document Section, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=4&tab=history) | `571df93f7b801bea22f1f571dc3abf184f388549e76a236dacc49edb1726db28` |
| 5 | 2025-05-12 | 2025-05-12 | COMPLETED | INTERVENTIONAL | Document Section, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=5&tab=history) | `521ad6ca3127c5bd404e43e2ddd0e5248374700ebbf0cd9337e6c2eabd1542e8` |
| 6 | 2025-06-30 | 2025-06-30 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, Document Section, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=6&tab=history) | `8675c2968c19dbf819564cd0569fab22e7f37d027c2ab287e4aa3de627bf3220` |
| 7 | 2025-08-21 | 2025-08-21 | COMPLETED | INTERVENTIONAL | Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT05530577?a=7&tab=history) | `7706d9214f2559a5ca78add0a9b74e098a778e57e0346d2973a99d25af632f3b` |